Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy

Project: Other project

Project Details

StatusActive
Effective start/end date3/27/203/26/24

Funding

  • Pfizer, Inc.: $9,300.00